Home › Funds › Millennium Management › NVCT
Millennium Management position in NVCT
NUVECTIS PHARMA INC · Health Care
Latest position (Q2 2025)31.17K sh
Reported value held$232.82K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 42.16K | $312.00K | New |
| Q1 2023 | 24.67K | $323 | New |
| Q4 2023 | 34.01K | $283.65K | New |
| Q1 2024 | 39.50K | $323.91K | Add |
| Q2 2024 | 119.46K | $756.17K | Add |
| Q3 2024 | 68.50K | $430.86K | Reduce |
| Q4 2024 | 29.70K | $160.67K | Reduce |
| Q1 2025 | 121.10K | $1.18M | Add |
| Q2 2025 | 31.17K | $232.82K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NVCT
- BlackRock Inc 1.00M sh · $18.41M · Q2 2026
- Geode Capital Management 432.27K sh · $7.95M · Q2 2026
- Vanguard Group 845.50K sh · $6.38M · Q4 2025
- Citadel Advisors 182.23K sh · $3.35M · Q2 2026
- Northern Trust Corp 146.71K sh · $2.70M · Q2 2026
- UBS Group AG 69.20K sh · $1.27M · Q2 2026
- Charles Schwab Investment Management 57.13K sh · $1.05M · Q2 2026
- BNY Mellon 36.77K sh · $676.19K · Q2 2026
- AQR Capital Management 31.89K sh · $586.38K · Q2 2026
- Goldman Sachs Group 20.48K sh · $376.63K · Q2 2026
- Morgan Stanley 18.72K sh · $344.28K · Q2 2026
- Deutsche Bank AG 16.87K sh · $310.31K · Q2 2026